Significant research among children, adolescents, & adults demonstrates that access to gender-affirming therapy and gender-affirming interventions greatly improves mental health, health outcomes, and saves lives. #TransHealthcare
We talked to Dr. Melina Wald about what it means to treat the whole person. Gender-affirming care is an evidence-based approach to health that is focused on instilling pride and celebration of gender diversity. columbiasurgery.org/news/what-gend…#ProtectTransYouth#TransIsBeautiful
Tomorrow! Join our Instagram live chat on gender identity care at 1pm. Feel free to DM us with your questions or bring them to the chat.
@TransEquality want to share the live chat we're doing tomorrow at 1pm. Will be a great resource for folks, if sharing/retweeting is something you do. Thanks!
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Interesting @NYPost story—do street lamps cause thyroid cancer? We asked endocrinologist Dr. Pinar Smith to give perspective. Thread 1/6 nypost.com/2021/02/08/str…
"The article raises the question: does 'light at night' specifically means city lights? Could someone watching TV or using their computer/device at night also influence risk? Maybe the study could have also incorporated 'screen time' after dark as a variable." 2/6
Heart failure deaths are increasing rapidly, and one key factor in the rise? The majority of treatment in the U.S. is stuck in the past, most physicians' mindsets haven't evolved. (thread)
"You know, [the rise in heart failure deaths] is a critical question not enough people are addressing," says @NirUrielMD. "Heart failure historically was a disease that a primary physician or cardiologist could treat, or theoretically, every doctor could. But it's evolved."
"Instead, [the majority of physicians] think they can take care of these patients, and when they identify that they cannot anymore and the patient is too sick, they offer the patient hospice care. Yet that patient missed out on the near entirety of treatment," says @NirUrielMD.
Donna Farber is an immunologist who studies the immune response to respiratory viruses, lung immunity, and human immunology. The COVID-19 and Immunology webinar starts now! Follow along #FarberCOVID19
COVID-19 symptom breakdown (based on 72,314 cases in China)
-1% asymptomatic
-81% acute disease w/out pneumonia
-14% severe disease
-5% critical
Case mortality=2.3% (*23 times more lethal than influenza) #FarberCOVID19
Risk factors for severe disease: middle to old age; male; comorbidities (heart disease, diabetes, hypertension)
Less than 10% of cases are under 30 years old.
Treatment is supportive care, no anti-viral or vaccine therapies #FarberCOVID19